Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data

INTRODUCTION: Triptans, the most commonly prescribed acute treatments for migraine attacks are, per FDA labeling, contraindicated in cardiovascular (CV) disease patients and have warnings and precautions for those with CV risk factors. METHODS: Headache specialists, cardiologists, and health economi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodick, David W., Shewale, Anand S., Lipton, Richard B., Baum, Seth J., Marcus, Steven C., Silberstein, Stephen D., Pavlovic, Jelena M., Bennett, Nathan L., Young, William B., Viswanathan, Hema N., Doshi, Jalpa A., Weintraub, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585888/
https://www.ncbi.nlm.nih.gov/pubmed/33095099
http://dx.doi.org/10.1177/2150132720963680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585888/
https://www.ncbi.nlm.nih.gov/pubmed/33095099
http://dx.doi.org/10.1177/2150132720963680

Ejemplares similares